Oppenheimer & Co. Inc. acquired a new stake in Pacer Trendpilot 100 ETF (NASDAQ:PTNQ – Free Report) during the third quarter, according to its most recent 13F filing with the SEC. The fund acquired 13,085 shares of the company’s stock, valued at approximately $1,167,000. Oppenheimer & Co. Inc. owned 0.09% of Pacer Trendpilot 100 ETF as of its most recent filing with the SEC.
A number of other institutional investors have also added to or reduced their stakes in the stock. Sigma Planning Corp bought a new position in Pacer Trendpilot 100 ETF in the third quarter valued at $936,000. Root Financial Partners LLC purchased a new position in Pacer Trendpilot 100 ETF during the 3rd quarter valued at $71,000. Retirement Planning Group LLC bought a new stake in shares of Pacer Trendpilot 100 ETF during the 3rd quarter valued at about $576,000. Gimbal Financial boosted its position in Pacer Trendpilot 100 ETF by 46.1% during the 3rd quarter. Gimbal Financial now owns 12,522 shares of the company’s stock valued at $1,117,000 after acquiring an additional 3,950 shares in the last quarter. Finally, Quantum Financial Partners LLC bought a new position in shares of Pacer Trendpilot 100 ETF in the 3rd quarter worth approximately $200,000.
Pacer Trendpilot 100 ETF Stock Performance
Shares of Pacer Trendpilot 100 ETF stock opened at $82.09 on Tuesday. The stock has a market capitalization of $1.16 billion, a PE ratio of 33.04 and a beta of 0.65. Pacer Trendpilot 100 ETF has a 52-week low of $71.56 and a 52-week high of $91.90. The company has a 50-day simple moving average of $87.33 and a two-hundred day simple moving average of $83.17.
Pacer Trendpilot 100 ETF Company Profile
The Pacer Trendpilot 100 ETF (PTNQ) is an exchange-traded fund that is based on the Pacer NASDAQ-100 Trendpilot index. The fund tracks an index that holds the NASDAQ-100 securities and/or 3-month US T-bills according to momentum. PTNQ was launched on Jun 11, 2015 and is managed by Pacer.
Featured Stories
- Five stocks we like better than Pacer Trendpilot 100 ETF
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AIāThese 5 Stocks Are Getting Paid
Receive News & Ratings for Pacer Trendpilot 100 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pacer Trendpilot 100 ETF and related companies with MarketBeat.com's FREE daily email newsletter.
